Related Experiment Video
Updated: Jul 4, 2026
08:03
Intracavernosal Pressure Recording to Evaluate Erectile Function in Rodents
Published on: June 6, 2018
Cerebral vasomotor reactivity is reduced in patients with erectile dysfunction
Edoardo Vicenzini1, Marta Altieri, Paolo Maria Michetti
1Department of Neurological Sciences, University of Rome, La Sapienza, Rome, Italy. edoardo.vicenzini@uniroma1.it
European Neurology
|June 6, 2008
Summary
Erectile dysfunction (ED) patients exhibit reduced cerebrovascular reactivity, indicating early endothelial damage. This suggests ED may signal subclinical cerebral vasomotor dysfunction.
Area of Science:
- Vascular Medicine
- Neurology
- Cardiology
Background:
- Erectile dysfunction (ED) is linked to diffuse atherosclerosis and early endothelial damage.
- ED can serve as an indicator of underlying vascular health issues.
Purpose of the Study:
- To investigate cerebrovascular reactivity in patients with isolated ED.
- To assess early arterial damage markers in ED patients compared to controls.
Main Methods:
- 15 patients with ED and 15 controls underwent carotid duplex ultrasound and transcranial Doppler.
- Cerebrovascular reactivity was measured using breath-holding and hyperventilation tests to calculate vasomotor range (VMR) and VMR/CO(2).
Main Results:
- No significant differences in intima-media thickness or carotid stenosis were found between groups.
- Patients with ED showed slightly slower middle cerebral artery flow velocities.
- Significantly reduced VMR and VMR/CO(2) were observed in ED patients compared to controls (p < 0.001).
Conclusions:
- Reduced cerebrovascular reactivity in ED patients suggests early cerebral vasomotor dysfunction.
- This dysfunction may stem from subclinical endothelial damage associated with ED.
Related Concept Videos
01:17Male Sexual Response: Erection & Ejaculation
Sexual stimulation can take various forms, such as physical touch and visual or auditory cues. When this happens, the parasympathetic reflex in the sacral portion of the spinal cord is activated. This reflex stimulates the release of nitric oxide (NO), which then dilates the arterioles in the penis, increasing blood flow to the erectile tissues - the corpora cavernosa and corpus spongiosum.
The blood filling the erectile tissues compresses the veins, which helps to prevent blood from leaving...
The blood filling the erectile tissues compresses the veins, which helps to prevent blood from leaving...
01:23Antihypertensive Drugs: Vasodilators
Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
01:18Disorders of the Autonomic Nervous System
The autonomic nervous system (ANS) is an intricate network of nerves that controls functions such as the regulation of heart rate, digestion, and blood pressure regulation. When this system malfunctions, it can lead to various disorders that affect multiple bodily functions. One common feature of many autonomic disorders is the involvement of smooth blood vessels, which play a crucial role in regulating blood flow throughout the body.
Raynaud's disease, also known as Raynaud's phenomenon, is a...
Raynaud's disease, also known as Raynaud's phenomenon, is a...
01:28Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
01:20Disorders of the Male Reproductive System
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...
01:17Autoregulation of Blood Flow
Autoregulation mechanisms are characterized by their inherent capacity for self-regulation without necessitating specific nervous stimulation or endocrine control. These mechanisms facilitate the adjustment of blood flow and, therefore, perfusion specific to each tissue region. This self-regulation encompasses chemical signals and myogenic controls.
Chemical Signaling in Autoregulation
Chemical signaling operates at the precapillary sphincter level, inciting either contraction or relaxation.
Chemical Signaling in Autoregulation
Chemical signaling operates at the precapillary sphincter level, inciting either contraction or relaxation.